Landis SH, Murray T, Bolden S, Wingo PA: Cancer statistics, 1998. CA Cancer J Clin. 1998, 48 (1): 6-29. 10.3322/canjclin.48.1.6.
Article
CAS
Google Scholar
Soignet SL, Maslak P, Wang ZG, Jhanwar S, Calleja E, Dardashti LJ, Corso D, DeBlasio A, Gabrilove J, Scheinberg DA, Pandolfi PP, Warrell RP: Complete remission after treatment of acute promyelocytic leukemia with arsenic trioxide. N Engl J Med. 1998, 339 (19): 1341-1348. 10.1056/NEJM199811053391901.
Article
CAS
Google Scholar
Shao W, Fanelli M, Ferrara FF, Riccioni R, Rosenauer A, Davison K, Lamph WW, Waxman S, Pelicci PG, Lo Coco F, Avvisati G, Testa U, Peschle C, Gambacorti-Passerini C, Nervi C, Miller WH: Arsenic trioxide as an inducer of apoptosis and loss of PML/RAR alpha protein in acute promyelocytic leukemia cells. J Natl Cancer Inst. 1998, 90 (2): 124-133. 10.1093/jnci/90.2.124.
Article
CAS
Google Scholar
Look AT: Arsenic and apoptosis in the treatment of acute promyelocytic leukemia. J Natl Cancer Inst. 1998, 90 (2): 86-88. 10.1093/jnci/90.2.86.
Article
CAS
Google Scholar
Chen GQ, Shi XG, Tang W, Xiong SM, Zhu J, Cai X, Han ZG, Ni JH, Shi GY, Jia PM, Liu MM, He KL, Niu C, Ma J, Zhang P, Zhang TD, Paul P, Naoe T, Kitamura K, Miller W, Waxman S, Wang ZY, de The H, Chen SJ, Chen Z: Use of arsenic trioxide (As2O3) in the treatment of acute promyelocytic leukemia (APL): I. As2O3 exerts dose-dependent dual effects on APL cells. Blood. 1997, 89 (9): 3345-3353.
CAS
Google Scholar
Shao ZM, Nguyen M, Alpaugh ML, O'Connell JT, Barsky SH: The human myoepithelial cell exerts antiproliferative effects on breast carcinoma cells characterized by p21WAF1/CIP1 induction, G2/M arrest, and apoptosis. Exp Cell Res. 1998, 241 (2): 394-403. 10.1006/excr.1998.4066.
Article
CAS
Google Scholar
Daigeler A, Brenzel C, Bulut D, Geisler A, Hilgert C, Lehnhardt M, Steinau HU, Flier A, Steinstraesser L, Klein-Hitpass L, Mittelkötter U, Uhl W, Chromik AM: TRAIL and Taurolidine induce apoptosis and decrease proliferation in human fibrosarcoma. J Exp Clin Cancer Res. 2008, 27: 82-10.1186/1756-9966-27-82.
Article
Google Scholar
Gurr JR, Bau DT, Liu F, Lynn S, Jan KY: Dithiothreitol enhances arsenic trioxide-induced apoptosis in NB4 cells. Mol Pharmacol. 1999, 56 (1): 102-109.
CAS
Google Scholar
Dong JT, Luo XM: Arsenic-induced DNA-strand breaks associated with DNA-protein crosslinks in human fetal lung fibroblasts. Mutat Res. 1993, 302 (2): 97-102. 10.1016/0165-7992(93)90010-S.
Article
CAS
Google Scholar
Ling YH, Jiang JD, Holland JF, Perez-Soler R: Arsenic trioxide produces polymerization of microtubules and mitotic arrest before apoptosis in human tumor cell lines. Mol Pharmacol. 2002, 62 (3): 529-538. 10.1124/mol.62.3.529.
Article
CAS
Google Scholar
Chen GQ, Zhu J, Shi XG, Ni JH, Zhong HJ, Si GY, Jin XL, Tang W, Li XS, Xong SM, Shen ZX, Sun GL, Ma J, Zhang P, Zhang TD, Gazin C, Naoe T, Chen SJ, Wang ZY, Chen Z: n vitro studies on cellular and molecular mechanisms of arsenic trioxide (As2O3) in the treatment of acute promyelocytic leukemia: As2O3 induces NB4 cell apoptosis with downregulation of Bcl-2 expression and modulation of PML-RAR alpha/PML proteins. Blood. 1996, 88 (3): I1052-1061.
Google Scholar
Kroemer G, de The H: Arsenic trioxide, a novel mitochondriotoxic anticancer agent?. J Natl Cancer Inst. 1999, 91 (9): 743-745. 10.1093/jnci/91.9.743.
Article
CAS
Google Scholar
Cao C, Shinohara ET, Li H, Niermann KJ, Kim KW, Sekhar KR, Gleave M, Freeman M, Lu B: Clusterin as a therapeutic target for radiation sensitization in a lung cancer model. Int J Radiat Oncol Biol Phys. 2005, 63 (4): 1228-1236.
Article
CAS
Google Scholar
Scaltriti M, Santamaria A, Paciucci R, Bettuzzi S: Intracellular clusterin induces G2-M phase arrest and cell death in PC-3 prostate cancer cells1. Cancer research. 2004, 64 (17): 6174-6182. 10.1158/0008-5472.CAN-04-0920.
Article
CAS
Google Scholar
Chi KN, Siu LL, Hirte H, Hotte SJ, Knox J, Kollmansberger C, Gleave M, Guns E, Powers J, Walsh W, Tu D, Eisenhauer E: A phase I study of OGX-011, a 2'-methoxyethyl phosphorothioate antisense to clusterin, in combination with docetaxel in patients with advanced cancer. Clin Cancer Res. 2008, 14 (3): 833-839. 10.1158/1078-0432.CCR-07-1310.
Article
CAS
Google Scholar
McCafferty-Grad J, Bahlis NJ, Krett N, Aguilar TM, Reis I, Lee KP, Boise LH: Arsenic trioxide uses caspase-dependent and caspase-independent death pathways in myeloma cells. Molecular cancer therapeutics. 2003, 2 (11): 1155-1164.
CAS
Google Scholar
Cai X, Shen YL, Zhu Q, Jia PM, Yu Y, Zhou L, Huang Y, Zhang JW, Xiong SM, Chen SJ, Wang ZY, Chen Z, Chen GQ: Arsenic trioxide-induced apoptosis and differentiation are associated respectively with mitochondrial transmembrane potential collapse and retinoic acid signaling pathways in acute promyelocytic leukemia. Leukemia. 2000, 14 (2): 262-270. 10.1038/sj.leu.2401650.
Article
CAS
Google Scholar
Karlsson J, Ora I, Porn-Ares I, Pahlman S: Arsenic trioxide-induced death of neuroblastoma cells involves activation of Bax and does not require p53. Clin Cancer Res. 2004, 10 (9): 3179-3188. 10.1158/1078-0432.CCR-03-0309.
Article
CAS
Google Scholar